0001209191-21-059374.txt : 20211005 0001209191-21-059374.hdr.sgml : 20211005 20211005161648 ACCESSION NUMBER: 0001209191-21-059374 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211001 FILED AS OF DATE: 20211005 DATE AS OF CHANGE: 20211005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Horn David R. CENTRAL INDEX KEY: 0001834217 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39747 FILM NUMBER: 211306820 MAIL ADDRESS: STREET 1: 3800 BRIDGE PARKWAY STREET 2: SUITE 102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seer, Inc. CENTRAL INDEX KEY: 0001726445 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 821153150 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3800 BRIDGE PARKWAY, SUITE 102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650-453-0000 MAIL ADDRESS: STREET 1: 3800 BRIDGE PARKWAY, SUITE 102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: Seer Biosciences, Inc. DATE OF NAME CHANGE: 20171226 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-10-01 0 0001726445 Seer, Inc. SEER 0001834217 Horn David R. C/O SEER, INC. 3800 BRIDGE PARKWAY, SUITE 102 REDWOOD CITY CA 94065 0 1 0 0 Chief Financial Officer Class A Common Stock 2021-10-01 4 M 0 10000 2.70 A 240966 D Class A Common Stock 2021-10-01 4 S 0 4964 33.4177 D 236002 D Class A Common Stock 2021-10-01 4 S 0 5036 34.2693 D 230966 D Employee Stock Option (right to buy) 2.70 2021-10-01 4 M 0 10000 0.00 D 2030-04-01 Class A Common Stock 10000 576547 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.86 to $33.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.86 to $34.61, inclusive. The shares underlying the option are subject to an early exercise provision and are immediately exercisable. One-fourth of the shares underlying the option vested on April 1, 2021 and 1/48th of the shares vest monthly thereafter. /s/ David R. Horn 2021-10-05